The Board of Directors of Beacon Pharmaceuticals Ltd. has recommended 16% cash dividend for the year ended on June 30, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
203 BDT | +3.62% | -3.20% | -17.14% |
1st Jan change | Capi. | |
---|---|---|
-17.14% | 427M | |
+17.51% | 44.31B | |
+19.87% | 22.17B | |
+14.97% | 14.62B | |
+8.65% | 13.12B | |
+39.61% | 11.58B | |
-8.96% | 6.96B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+6.50% | 5.03B |
- Stock Market
- Equities
- BEACONPHAR Stock
- News Beacon Pharmaceuticals PLC
- Beacon Pharmaceuticals Ltd. Recommends Cash Dividend for the Year Ended on June 30, 2022